These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 21364995

  • 1. Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis.
    Davis JS, Darcy CJ, Yeo TW, Jones C, McNeil YR, Stephens DP, Celermajer DS, Anstey NM.
    PLoS One; 2011 Feb 18; 6(2):e17260. PubMed ID: 21364995
    [Abstract] [Full Text] [Related]

  • 2. Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients.
    Visser M, Vermeulen MA, Richir MC, Teerlink T, Houdijk AP, Kostense PJ, Wisselink W, de Mol BA, van Leeuwen PA, Oudemans-van Straaten HM.
    Br J Nutr; 2012 May 18; 107(10):1458-65. PubMed ID: 22129964
    [Abstract] [Full Text] [Related]

  • 3. Asymmetric dimethylarginine and L-arginine levels in neonatal sepsis and septic shock.
    Aydemir O, Ozcan B, Yucel H, Bas AY, Demirel N.
    J Matern Fetal Neonatal Med; 2015 May 18; 28(8):977-82. PubMed ID: 24983667
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Markers of nitric oxide are associated with sepsis severity: an observational study.
    Winkler MS, Kluge S, Holzmann M, Moritz E, Robbe L, Bauer A, Zahrte C, Priefler M, Schwedhelm E, Böger RH, Goetz AE, Nierhaus A, Zoellner C.
    Crit Care; 2017 Jul 15; 21(1):189. PubMed ID: 28709458
    [Abstract] [Full Text] [Related]

  • 8. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.
    Chen JW, Hsu NW, Wu TC, Lin SJ, Chang MS.
    Am J Cardiol; 2002 Nov 01; 90(9):974-82. PubMed ID: 12398965
    [Abstract] [Full Text] [Related]

  • 9. High Levels of Methylarginines Were Associated With Increased Mortality in Patients With Severe Sepsis.
    Mortensen KM, Itenov TS, Haase N, Müller RB, Ostrowski SR, Johansson PI, Olsen NV, Perner A, Søe-Jensen P, Bestle MH.
    Shock; 2016 Oct 01; 46(4):365-72. PubMed ID: 27206279
    [Abstract] [Full Text] [Related]

  • 10. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.
    Kielstein JT, Böger RH, Bode-Böger SM, Schäffer J, Barbey M, Koch KM, Frölich JC.
    J Am Soc Nephrol; 1999 Mar 01; 10(3):594-600. PubMed ID: 10073610
    [Abstract] [Full Text] [Related]

  • 11. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K, Hornig B, Arakawa N, Bode-Böger SM, Tsikas D, Münzel T, Böger RH.
    Vasc Med; 2004 May 01; 9(2):93-101. PubMed ID: 15521698
    [Abstract] [Full Text] [Related]

  • 12. The effects of renal replacement therapy on plasma, asymmetric dimethylarginine, nitric oxide and C-reactive protein levels.
    Uzun H, Konukoglu D, Besler M, Erdenen F, Sezgin C, Muderrisoglu C.
    Clin Invest Med; 2008 May 01; 31(1):E1-7. PubMed ID: 18312743
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
    Gates PE, Boucher ML, Silver AE, Monahan KD, Seals DR.
    J Appl Physiol (1985); 2007 Jan 01; 102(1):63-71. PubMed ID: 16946027
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
    Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP.
    Circulation; 1998 Nov 03; 98(18):1842-7. PubMed ID: 9799202
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Asymmetric dimethylarginine plasma levels and endothelial function in newly diagnosed type 2 diabetic patients.
    Sciacqua A, Grillo N, Quero M, Sesti G, Perticone F.
    Int J Mol Sci; 2012 Oct 24; 13(11):13804-15. PubMed ID: 23203035
    [Abstract] [Full Text] [Related]

  • 19. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension.
    Curgunlu A, Uzun H, Bavunoğlu I, Karter Y, Genç H, Vehid S.
    J Hum Hypertens; 2005 Aug 24; 19(8):629-33. PubMed ID: 15829997
    [Abstract] [Full Text] [Related]

  • 20. Monitoring of L-Arginine and Endogenous Dimethylarginines in Survivor Septic Patients - A Pilot Study.
    Németh B, Kiss I, Péter I, Ajtay Z, Németh Á, Márk L, Csorba A, Kőszegi T, Mühl D, Kustán P.
    In Vivo; 2005 Aug 24; 30(5):663-9. PubMed ID: 27566088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.